NXG stock news · NexgenRx Inc.
Get alerts for NXG
Follow NexgenRx Inc. (NXG) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NXGFree on the App Store and Google Play, or on the web.
NexgenRx shared its Q3 2026 results, with revenues up 8% and a big jump in income before taxes.
Good for NXGNexgenRx's Q3 sales rose 8% to $4.9 million. EBITDA rose 18.1% to $1,048,210, but a $907,728 tax charge caused a $63,993 loss.